1800-272-662
Shopping Cart 0
countryflagAU
Login

Control Bionics Ltd

Healthcare AU CBL

0.055AUD
0.001(1.85%)

Last update at 2026-03-13T03:06:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.030.09
LowHigh

Fundamentals

  • Previous Close 0.05
  • Market Cap22.25M
  • Volume551657
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.25811M
  • Revenue TTM6.07M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 3.81M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -6.10867M -5.91378M -5.63114M -6.10122M -3.55083M
Minority interest - - - - -
Net income -6.10867M -5.91378M -5.63114M -6.11011M -3.55083M
Selling general administrative 1.54M 5.67M 5.29M 4.91M 3.33M
Selling and marketing expenses 0.41M 0.46M 0.62M 0.71M 0.44M
Gross profit 4.11M 3.90M 3.71M -2.91368M 2.50M
Reconciled depreciation - 0.84M 0.48M 0.51M 0.20M
Ebit -5.95744M -5.85750M -5.61883M -6.42895M -3.59680M
Ebitda -5.13950M -5.01431M -5.13838M -5.92110M -3.39826M
Depreciation and amortization 0.82M 0.84M 0.48M 0.51M 0.20M
Non operating income net other - - - - -
Operating income -5.82961M -5.92927M -5.20619M -6.01371M -2.95011M
Other operating expenses 11.97M 12.22M 11.72M 10.99M 7.04M
Interest expense 0.11M 0.06M 0.02M 0.01M 0.07M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.18M 0.01M 0.02M 0.00133M 0.00116M
Net interest income - -0.04410M -0.00119M -0.04167M -0.06921M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.42663M -0.85040M -0.41281M -0.33846M -0.11634M
Total revenue 6.14M 5.35M 5.64M 4.50M 4.09M
Total operating expenses 9.94M 4.47M 4.22M 9.01M 5.61M
Cost of revenue 2.03M 1.45M 1.93M 7.42M 1.43M
Total other income expense net -0.27906M 0.02M -0.42495M -0.08752M -0.60071M
Discontinued operations - - - - -
Net income from continuing ops - -5.91378M -5.63114M -6.10122M -3.55083M
Net income applicable to common shares -6.10867M -5.91378M -5.63114M -6.10122M -3.55083M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 8.23M 9.03M 8.70M 13.44M 18.35M
Intangible assets 3.88M - 4.11M 4.07M 4.08M
Earning assets - - - - -
Other current assets 0.69M 0.19M 0.20M 0.71M 0.11M
Total liab 2.72M 2.76M 1.55M 1.51M 1.19M
Total stockholder equity 5.51M 6.27M 7.15M 11.92M 17.16M
Deferred long term liab - - - - -
Other current liab 0.86M 0.85M 0.89M 0.77M 0.70M
Common stock 40.37M 35.15M 30.24M 29.27M 28.17M
Capital stock - - 30.24M 29.27M 28.17M
Retained earnings -35.38782M -29.27916M -23.36538M -17.73424M -11.63301M
Other liab - - 0.02M 0.03M 0.02M
Good will - - - - -
Other assets - - 0.00000M 0.02M 0.02M
Cash 0.59M 0.98M 0.94M 5.21M 12.33M
Cash and equivalents - - - - -
Total current liabilities 2.55M 2.40M 1.53M 1.36M 1.17M
Current deferred revenue - 0.32M - - -
Net debt -0.15934M -0.01902M -0.80700M -4.92918M -12.31624M
Short term debt 0.30M 0.63M 0.13M 0.16M 0.01M
Short long term debt - - - 0.05M -
Short long term debt total 0.44M 0.96M 0.13M 0.28M 0.01M
Other stockholder equity - - 0.09M 0.39M 0.62M
Property plant equipment - - 0.72M 0.71M 0.53M
Total current assets 3.17M 3.76M 3.87M 8.61M 13.72M
Long term investments - - - - -
Net tangible assets - - 3.04M 7.83M 13.08M
Short term investments 0.08M - - - -
Net receivables 1.40M 2.19M 1.78M 1.76M 1.12M
Long term debt - - - - 0.00000M
Inventory 0.41M 0.40M 0.80M 0.92M 0.27M
Accounts payable 1.39M 0.61M 0.52M 0.43M 0.46M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.53M 0.39M 0.27M 0.39M 0.62M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 4.05M - 0.02M 0.02M
Deferred long term asset charges - - - - -
Non current assets total 5.06M 5.27M 4.83M 4.83M 4.63M
Capital lease obligations - - 0.13M 0.24M 0.01M
Long term debt total - - 0.00000M 0.12M 0.00000M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - -0.47309M -0.45754M -0.14774M -0.05340M
Change to liabilities - - 0.32M -0.01436M 0.44M
Total cashflows from investing activities -0.74478M -0.47309M -0.45754M -0.14774M -0.05340M
Net borrowings - 0.52M -0.15632M -0.04518M -0.04521M
Total cash from financing activities 4.63M 5.43M 0.71M -0.08732M 14.92M
Change to operating activities - - -0.31441M 0.06M 0.03M
Net income -6.10867M -5.91378M -5.63114M -6.11011M -3.55083M
Change in cash -0.38603M 0.05M -4.27850M -7.11711M 10.90M
Begin period cash flow 0.98M 0.94M 5.21M 12.33M 1.43M
End period cash flow 0.59M 0.98M 0.94M 5.21M 12.33M
Total cash from operating activities -4.26932M -4.91190M -4.52739M -6.88694M -3.99063M
Issuance of capital stock - 5.09M 0.75M 0.01M 15.68M
Depreciation 0.99M 0.84M 0.48M 0.51M 0.20M
Other cashflows from investing activities -0.44245M -0.07475M -0.03742M - -0.00524M
Dividends paid - - - - 0.05M
Change to inventory -0.00549M -0.04842M 0.12M -0.65458M -0.09005M
Change to account receivables -0.06984M -0.76055M -0.23533M -0.41546M -0.80406M
Sale purchase of stock 5.41M -0.11448M 0.86M 0.01M -0.71529M
Other cashflows from financing activities -0.42219M -0.06923M -0.04820M -0.00799M -0.04521M
Change to netincome - - 0.74M -0.27359M -0.21579M
Capital expenditures 0.30M 0.47M 0.46M 0.15M 0.05M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.03059M -0.46264M -0.11184M -1.01997M -0.42255M
Stock based compensation 0.12M 0.14M 0.04M 0.05M 0.09M
Other non cash items 0.76M 0.62M 1.50M 4.32M 0.64M
Free cash flow -4.57165M -5.38499M -4.98493M -5.75000M -4.04403M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CBL
Control Bionics Ltd		 0.001 1.85% 0.06 - - 3.67 3.04 3.47 -2.2282
COH
Cochlear Ltd		 -4.74 2.65% 174.42 33.10 26.39 4.88 6.04 5.59 23.13
4DX
4DMEDICAL Ltd		 -0.15 3.55% 4.07 - - 401.92 37.59 417.71 -7.2899
AVR
Anteris Technologies Global Corp		 - -% 9.10 - - 475.96 166.77 334.65 -5.1986
PNV
Polynovo Ltd		 - -% 0.94 94.00 30.21 4.66 7.81 4.68 93.96

Reports Covered

Stock Research & News

View All

Profile

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally. It offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. The company also provides the NeuroStrip, a wearable, miniaturized electromyography device; NeuroNode, a wireless, wearable sensor that allows users to access technology through bioelectric signals and spatial movements; and Cosmos Connect, a small portable control device that turns a single NeuroNode sensor into multiple outputs. In addition, it offers mounting systems under the Rehadapt brand, including wheelchair mounts, floor stands, and table stands; switch systems comprising proximity, press, and finger switches; and the autonomous wheelchair module under the DROVE brand. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is headquartered in Cremorne, Australia.

Control Bionics Ltd

11-13 Pearson Street, Cremorne, VIC, Australia, 3121

Key Executives

Name Title Year Born
Mr. Peter Shann Ford Founder, Interim CEO, Exec. Director & Director of Innovation NA
Mr. Robert William Wong Exec. Director NA
Mr. Todd Tyler US Country Mang. NA
Dominik Kucera Interim Chief Financial Officer NA
Mr. James Schorey Chief Technology Officer NA
Ms. Meagan Koeneman Sales Director NA
Mr. Brett Thomas Crowley B.Com., BCom, C.A., CA, DipLaw Company Sec. 1957
Mr. Jeremy E. Steele CEO, MD & Director NA
Mr. Peter Shann Ford Founder & Non-Executive Director NA
Mr. Dominik Kucera Interim Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.